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This study focuses on gene expression patterns and functions in human umbilical cord (UC) and dental pulp (DP) containing
mesenchymal stem cells (MSCs). DP tissues were collected from 25 permanent premolars. UC tissue samples were obtained
from three newborns. Comparative gene profiles were obtained using cDNA microarray analysis and the expression of tooth
development-associated and MSC-related genes was assessed by the quantitative real-time reverse transcription polymerase chain
reaction (qRT-PCR). Genes related to cell proliferation, angiogenesis, and immune responses were expressed at higher levels in UC,
whereas genes related to growth factor and receptor activity and signal transduction were more highly expressed in DP. Although
UC andDP tissues exhibited similar expression of surfacemarkers forMSCs, UC showed higher expression of CD29, CD34, CD44,
CD73, CD105, CD146, and CD166. qRT-PCR analysis showed that CD146, CD166, and MYC were expressed 18.3, 8.24, and 1.63
times more highly in UC, whereas the expression of CD34 was 2.15 times higher in DP. Immunohistochemical staining revealed
significant differences in the expression of genes (DSPP, DMP1, and CALB1) related to odontogenesis and angiogenesis in DP. DP
and UC tissue showed similar gene expression, with the usual MSC markers, while they clearly diverged in their differentiation
capacity.
1. Introduction
Mesenchymal stem cells (MSCs) have attracted a great deal of
interest because of their potential application in regenerative
medicine and tissue engineering. MSCs are highly prolifer-
ative and adherent fibrotic cells that express characteristic
cell surface markers and retain self-renewing capacity with
the potential of differentiating into various tissues including
bone, muscle, cartilage, fat, and nerve [1]. MSCs may be
isolated readily from several tissues such as bone marrow,
adipose tissue, and placenta [2]. Although MSCs derived
from bonemarrow are well characterized, the harvest of stem
cells from the bone marrow is a highly invasive procedure
with a considerable risk of donor site morbidity.
Recently, potential alternative sources of MSCs and non-
aggressive methods for the harvesting of stem cells have been
investigated; in particular, the umbilical cord (UC) and dental
pulp (DP) show great promise as source tissues because
they contain a considerable number of cells with properties
similar to those of MSCs [3, 4]. In recent years, UC-
MSCs have shown an odontogenic differentiation potential
to differentiate into odontoblast-like cells in an odontogenic
microenvironment [5].
UC tissue (Wharton’s jelly of human umbilical cord) is
considered an ideal source of stem cells with characteristics
similar to those of MSCs from bone marrow and adipose
tissue, for example, fibroblast morphology, surface protein
markers, and potential for differentiation into cells of ther-
apeutic value [6, 7]. UC cells exhibit immunosuppressive
capacity and high proliferation rates, which are useful in allo-
geneic environments [8, 9].DP,which is thought to be derived
from migratory neural crest cells during development, is
Hindawi Publishing Corporation
Stem Cells International
Volume 2016, Article ID 3453890, 12 pages
http://dx.doi.org/10.1155/2016/3453890
2 Stem Cells International
a source of various populations of multipotent stem cells [10].
Similar toMSCs, dental pulp stem cells (DPSCs) are adherent
clonogenic cells with varying capacities for differentiation
along mesenchymal or nonmesenchymal lineages [11].
The UC is a potentially valuable source of MSCs as the
isolation process is noninvasive and causes no harm to the
mother or infant andutilizesmaterial that is usually discarded
[12]. In addition, UC tissue is derived from the neonate and is
therefore less mature than adult tissues. This lowers the risk
of immune reactions during donor transplantation. DPSCs
also represent a valuable source of MSCs, as the latter may be
obtained with minimal pain and morbidity [13]. Therefore,
MSCs derived from the UC and DP are more desirable
for stem cell-based therapy than stem cells obtained from
conventional sources such as bone marrow.
Despite extensive knowledge of the properties of UC-
MSCs and DPSCs, it is still not known whether their prop-
erties accurately reflect their true gene expression patterns
and developmental potential in situ. The fate of stem cells is
regulated by cell-intrinsic determinants and signals within a
specialized microenvironment [14]. Therefore, investigation
of the genes related to stemness in UC and DP is necessary
in order to evaluate the potential value of these tissues
as alternative sources of MSCs. In particular, their gene
expression patterns must be analyzed to obtain insights into
the differentiation capacity of the stem cells and to compare
the biological functions of the stemness-related genes in
terms of interactions with the microenvironment. In this
study, we performed a DNA microarray-based differential
gene expression analysis of UC and DP tissues with the aim
of comparing the characteristics of MSCs from each type of
tissue.
2. Materials and Methods
2.1. Tissue Samples. The experimental protocol was approved
by the Institutional Review Board of Yonsei University Dental
Hospital (#2-2012-0001) and Severance Hospital (#4-2012-
0408). All the subjects or their guardians have provided
written informed consent. Pulp samples were obtained from
healthy permanent premolars (𝑛 = 25; from 5 males and 6
females, aged 11–25 years) extracted for orthodontic reasons.
The fresh umbilical cord tissues were obtained from three
newborns in the Department of Obstetrics and Gynecology,
Severance Hospital, Yonsei University. The extracted teeth
and umbilical cords were frozen immediately and stored in
liquid nitrogen. The pulp tissue was obtained using sterile
tweezers and barbed broaches. The UC tissue was sliced at
a thickness of 10–14 𝜇m using a cryostat (CM3050S, Leica
Biosystems, Newcastle Upon Tyne, UK). Subsequently, the
DP and UC tissues were immediately submerged in Buffer
RLT, which is a proprietary component of the RNeasy Fibrous
Mini Kit (Qiagen, Valencia, CA, USA).
2.2. RNA Extraction. We used similar study procedures
applied by Song et al. [15], Lee et al. [16], and Kim et al.
[17]. Total RNA was extracted from DP and UC tissues
using the RNeasy Fibrous Mini Kit (Qiagen) according to
the manufacturer’s instructions. The extracted RNA was
eluted in 25 𝜇L of sterile water. Prior to RNA extraction,
tissues were homogenized using a Bullet BlenderBead (Next
Advanced, Averill Park, NY, USA). RNA concentrations
were determined from absorbance values at a wavelength of
260 nm using a spectrophotometer (Nanodrop ND-1000,
Thermo Scientific, Waltham, MA, USA). RNA samples used
in this study had 260/280 nm ratios equal to or greater than
1.8.
2.3. cDNAMicroarray. Global gene expression analyses were
performed using GeneChip Human Gene 1.0 ST oligonu-
cleotide arrays (Affymetrix, Santa Clara, CA, USA). The
average amount of RNA isolated from DP and UC tis-
sues was 1 𝜇g. Total RNA was isolated using the RNeasy
Fibrous Mini Kit columns as described by the manufac-
turer (Qiagen). RNA quality was assessed using the Agilent
2100 Bioanalyzer with an RNA 6000 Nano Chip (Agilent
Technologies, Amstelveen, Netherlands). RNA quantity was
determined using theNanodropND-1000. Each RNA sample
was subjected to global gene expression analysis according to
the manufacturer’s protocol (http://www.affymetrix.com/).
Briefly, 300 ng of total RNA from each sample was con-
verted to double-stranded cDNA. Using a random hex-
amer incorporating a T7 promoter, amplified RNA (cRNA)
was generated from the double-stranded cDNA template
via an in vitro transcription reaction and was purified
using the Affymetrix sample cleanup module. cDNA was
generated by random-primer reverse transcription using a
dNTP mix containing dUTP. The cDNA was then frag-
mented using the restriction endonucleases uracil-DNA
glycosylase and human apurinic/apyrimidinic endonuclease.
Next, the fragmented cDNA was end-labeled via a terminal
transferase reaction incorporating a biotinylated dideoxynu-
cleotide. Fragmented end-labeled cDNA was hybridized to
the GeneChip Human Gene 1.0 ST array for 16 h at 45∘C
and 60 rpm as described in the GeneChip Whole Tran-
script Sense Target Labeling Assay Manual (Affymetrix).
After hybridization, the chips were stained and washed
in a GeneChip Fluidics Station 450 and scanned using a
GeneChip Array scanner 3000 G7 (Affymetrix). The image
data were extracted using Command Console software 1.1
(Affymetrix) and a raw file containing the expression inten-
sity data was generated and used for the next step. This
microarray data set was approved by the Gene Expression
Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/); the
GEO accession numbers of the data set are GSE75642
(umbilical cord) and GSE75644 (dental pulp).
2.4. Gene Ontology Analysis. Expression data were generated
using Expression Console software version 1.1 (Affymetrix).
For normalization, the Robust Multiarray Average algorithm
of the Expression Console software was used. In order to
determine whether genes were differentially expressed in the
three groups, a one-way ANOVA was performed on the
RobustMultiarrayAverage expression values. Amultiple test-
ing correctionwas applied to the𝑝 values of the𝐹-statistics to
adjust the false discovery rate. Genes with adjusted 𝐹-statistic
𝑝 values < 0.05 were extracted. Highly expressed genes that
showed over 2-fold differences between the signal values in
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Table 1: Quantitative RT-PCR primer lists.
Gene symbol Gene description Assay ID Amplicon length
AMBN Ameloblastin (enamel matrix protein) Hs00212970 m1 61
ALCAM (CD166) Activated leukocyte cell adhesion molecule Hs00977641 m1 103
CALB1 Calbindin 1 Hs00191821 m1 90
CD34 CD34 molecule Hs00990732 m1 91
DMP1 Dentin matrix acidic phosphoprotein 1 Hs01009391 g1 106
DSPP Dentin sialophosphoprotein Hs00171962 m1 67
MCAM (CD146) Melanoma cell adhesion molecule Hs00174838 m1 77
MYC c-Myc Hs00153408 m1 107
18S 18S rRNA Hs03003631 g1 69
the control and each test group were selected for further
investigation. In order to classify the coexpression gene group
with a similar expression pattern, we performed hierarchical
and 𝐾-mean clustering using MultiExperiment Viewer soft-
ware 4.4 (http://www.tm4.org/, Dana-Farber Cancer Insti-
tute, Boston, MA, USA). The web-based tool, DAVID (the
Database for Annotation, Visualization, and Integrated Dis-
covery), was used for biological interpretation of differ-
entially expressed genes. Subsequently, these genes were
classified based on their function according to the KEGG
Pathway database (https://david.ncifcrf.gov/home.jsp).
2.5. Quantitative Reverse Transcription Polymerase Chain
Reaction. The single-stranded cDNA required in the PCR
analysis step was produced using 500 ng of extracted total
RNA as a template for reverse transcription (Superscript
III Reverse Transcriptase and Random Primer, Invitrogen,
Paisley, UK). The reverse transcription reaction was per-
formed at 65∘C for 5 minutes, followed by 25∘C for 5 minutes,
50∘C for 1 hour, and 70∘C for 15 minutes to inactivate the
reverse transcriptase. The synthesized cDNA was diluted
10 : 1 in distilled water and used as a template for qRT-
PCR, which was performed using the ABI7300 RT-PCR
system (Applied Biosystems, Warrington, UK). Samples of
25 𝜇L containing 1x Universal TaqManMaster Mix (4369016,
Applied Biosystems), PCR primers at a concentration of
0.9 𝜇M, and the diluted cDNAwere prepared in triplicate.The
amplification conditions were 50∘C for 2 minutes and 95∘C
for 10 minutes followed by 40 cycles of 95∘C for 15 seconds
and 60∘C for 1minute. TaqMan gene expression assay primers
(Applied Biosystems) were used. The primers for each gene
are listed in Table 1. ABI 7300 SDS 1.3.1 software (Applied
Biosystems) was used to record the fluorescence intensity of
the reporter and quencher dyes. Fluorescence intensity values
were plotted against time and quantified as the cycle number.
A precise quantification of the initial target was obtained by
examining the amplification plots during the early log phase
of product accumulation above background (the threshold
cycle (Ct) number). Ct values were subsequently used to
determine ΔCt values (ΔCt = Ct of the gene minus Ct of
the 18S rRNA gene control), and differences in Ct values
were used to quantify the relative amount of PCR product,
expressed as the relative change by applying the equation
2
−ΔCt.The specific primer assay ID and product sizes for each
gene are listed in Table 1.
2.6. Immunohistochemical Staining. For IHC staining, tissues
from permanent teeth and the UC were fixed in 10% buffered
formalin (Sigma-Aldrich, St. Louis, MO, USA) for 1 day.
Permanent teeth were decalcified using 10% EDTA (pH 7.4;
Thermo Fisher Scientific, Houston, TX, USA) for 8 weeks.
The permanent teeth and UC tissues were embedded in
paraffin and sectioned at a thickness of 3 𝜇m. Specimens
were subjected to IHC staining with antibodies against
DSPP (rabbit polyclonal, diluted 1 : 1500; sc-33586, Santa
Cruz Biotechnology, Santa Cruz, CA, USA), DMP1 (rabbit
polyclonal, diluted 1 : 100; Ab82351, Abcam), CALB1 (rabbit
polyclonal, diluted 1 : 400; Ab25085, Abcam), and CD146
(MCAM, rabbit polyclonal, diluted 1 : 400; Ab75769, Abcam).
Endogenous peroxidase activity was quenched by the addi-
tion of 3% hydrogen peroxide. Sections were incubated in
5% bovine serum albumin to block nonspecific binding. The
primary antibodies were diluted to obtain optimal staining
and sections were incubated overnight. After incubation,
the EnVision+ System-HRP Labeled Polymer Anti-Rabbit
kit (K4003, Dako, Carpinteria, CA, USA; ready to use) was
applied for 20 minutes. Color development was performed
using labeled streptavidin biotin kits (Dako) according to
the manufacturer’s instructions. The sections were coun-
terstained with Gill’s hematoxylin (Sigma-Aldrich). Control
sections were treated in the same manner but without
primary antibodies.
3. Results
3.1. Gene Expression Profiles of UC and DP Tissues. Com-
plementary DNA microarray technology was used to com-
pare multiple gene expression profiles representative of DP
and UC tissues. In order to investigate these differentially
expressed genes further, data with a more stringent thresh-
old of 3-fold differential expression were filtered to ensure
biological significance. The results indicated that 1,957 out of
33,297 (5.88%) genes exhibited an absolute expression change
at least 3-fold. The expression levels of 988 genes were 3-fold
higher in the UC than in DP tissues, while the expression
levels of 969 genes were at least 3-fold higher in DP than in
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Figure 1: Main categories of genes expressed specifically in umbilical cord and dental pulp classified according to their biological (a) and
molecular functions (b). Genes related to cell proliferation and angiogenesis were expressed at higher levels in the UC than in DP (𝑝 < 0.05).
UC tissues. The data were further filtered, and the genes are
listed in Tables 2 and 3 according to their biological functions.
3.2. Gene Ontology Analysis. In the UC tissue, the expression
levels of 158 genes were upregulated 10-fold or more in
comparison with DP, whereas the expression levels of 118
genes were upregulated 10-fold in DP in comparison with
UC. Genes related to cell proliferation and angiogenesis
were expressed at higher levels in UC than in DP. Lipid
metabolic process-related genes were highly expressed in DP.
In comparison with DP, a large proportion of the UC genes
were related to growth factor activity, structural molecular
activity, DNA binding, and protein binding (Figure 1).
3.3. Stemness Characterization Using Surface Protein Markers.
The comparative expression results for MSC surface protein
markers are indicated in Figure 3. UC tissue appeared to
contain a population of cells that were more positive for
MSC markers (including CD29, CD34, CD44, CD73, CD105,
CD146, and CD166) according to the minimal criteria of the
International Society for Cell Therapy [18]. The comparative
expression analysis of four induced pluripotent stem cell
(iPSC) marker genes (i.e., OCT4, SOX2, MYC, and KLF4)
revealed that the expression level of these genes was the
same in UC and DP. qRT-PCR analysis for eight impor-
tant marker genes revealed four tooth-related genes (DSPP,
AMBN, CALB1, and DMP1), three genes for MSCs (CD34,
CD146, and CD166), and MYC related to iPSC stemness.
DSPP, AMBN, CALB1, and DMP1 were expressed in DP
tissue but they were not excluded in the comparative qPCR
results because they were not detected in UC tissue. The
expression levels of CD146, CD166, andMYC were 18.3, 8.24,
and 1.63 times higher, respectively, in UC than in DP, and the
expression level of CD34 was 2.15 times higher in DP than in
UC (Figure 2).
3.4. Immunohistochemical Staining. MCAM (CD146) was
expressed abundantly as a perivascular stem cell marker
in connective tissue, especially in the arteries of the UC.
However, this protein showed a very low level of expression in
DP tissue (Figure 3). IHC staining showed that DSPP, DMP1,
and CALB1 were expressed broadly in DP tissue (Figure 4),
but barely expressed in the UC. DSPP was evident in pulpal
tissue, the odontoblast layer, and primary and secondary
dentin. While DMP was stained in the odontoblast layer and
secondary dentin, CALB1 was expressed in pulpal tissue and
the odontoblast layer.These findings were consistent with the
microarray data.
4. Discussion
Although numerous studies have been performed to evaluate
the utility of human MSCs as sources for the development
of cell-based therapeutics, a precise understanding of the
biology of MSCs remains elusive. Previous studies, based on
a strict definition of MSCs at the molecular or cellular levels,
involved serial analyses of gene expression. However, such
approaches raised concerns that the expression of house-
keeping genes may have interfered with the identification
of MSC-specific genetic characteristics. To overcome such
shortcomings, we examined DNA microarray-based differ-
ential expression profiles of MSC population, comparing
these profiles with those of other tissues to evaluate stemness
capacity. We compared DP with UC tissue as both types
contain stromal stem cell populations with high proliferative
potential that are capable of regenerating their respective
microenvironments with remarkable fidelity [19]. In order
to identify genes expressed at higher levels in UC than in
DP tissue, we categorized genes according to the ratio of the
fold change between the two tissues. Results of qRT-PCR and
IHC staining analyses confirmed the validity of these data,
indicating that the expression of representative genes was
consistent with the differential expression patterns observed
in the microarray data.
Although MSCs originating from both tissues are highly
similar, their differences may be functionally related to their
origin; for example, MSCs derived from DP are more com-
mitted to the osteoblastic and odontogenic lineages, whereas
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Table 2: Representative differentially expressed genes with higher expression levels in umbilical cord than in dental pulp tissue.
Functional category Genesymbol Biological process Accession number
Absolute fold
change
Embryonic
development
DLK1 Embryonic skeletal systemdevelopment NM 003836 56.86
DKK1 Embryonic limb morphogenesis NM 012242 44.51
SCEL Epidermis development, embryodevelopment NM 144777 33.26
TBX18 Morphogenesis of embryonicepithelium NM 001080508 15.66
HOXD10 Embryonic skeletal systemmorphogenesis NM 002148 12.03
TBX20 Embryonic heart tubedevelopment NM 001077653 11.71
HOXC10 Embryonic limb morphogenesis NM 017409 8.70
HOXC6 Embryonic skeletal systemdevelopment NM 004503 7.22
HAND2 In utero embryonic development NM 021973 6.54
HOXA6 Embryonic skeletal systemmorphogenesis NM 024014 5.50
EDN1 In utero embryonic development NM 001955 5.35
WNT4 Embryonic epithelial tubeformation NM 030761 4.31
GATA6 In utero embryonic development NM 005257 4.17
TGFB1I1 Morphogenesis of embryonicepithelium NM 001042454 4.13
TGFB3 In utero embryonic development NM 003239 3.85
SOX5 In utero embryonic development NM 152989 3.70
Developmental
process
DES Cytoskeleton organization NM 001927 66.18
KRT6A Ectoderm development NM 005554 27.69
KRT5 Epidermis development NM 000424 22.73
KRT13 Epidermis development, tonguemorphogenesis NM 153490 22.53
COL12A1 Skeletal system development,collagen fibril organization NM 004370 17.87
DKK2 Multicellular organismaldevelopment NM 014421 12.63
TAGLN Muscle organ development NM 001001522 11.91
KRT8 Cytoskeleton organization NM 002273 11.04
KRT14 Epidermis development NM 000526 9.01
OSTN Ossification, multicellularorganismal development NM 198184 8.22
MCAM Anatomical structuremorphogenesis NM 006500 7.22
IGF2BP3 Anatomical structuremorphogenesis NM 006547 7.10
ADAM19 Fertilization, muscledevelopment, neurogenesis NM 033274 6.41
MGP Cartilage condensation,ossification NM 001190839 5.70
DMD
Muscle organ development,
skeletal muscle tissue
development
NM 000109 5.22
PITX2 Multicellular organismaldevelopment NM 153426 4.79
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Table 2: Continued.
Functional category Genesymbol Biological process Accession number
Absolute fold
change
Physiological process
ACTG2 Muscle contraction NM 001615 115.24
HBG1 Transport NM 000559 101.65
PLN Cellular calcium ionhomeostasis, blood circulation NM 002667 71.69
CNN1 Regulation of smooth musclecontraction NM 001299 66.37
HBB Regulation of blood pressure,oxygen transport NM 000518 38.48
FGF10 Angiogenesis NM 004465 31.24
COL8A1 Angiogenesis NM 001850 12.02
AHSP Hemoglobin metabolic process,hematopoiesis NM 016633 7.18
FGF9 Angiogenesis, osteoblastdifferentiation NM 002010 5.07
PDGFA Angiogenesis, response tohypoxia NM 002607 5.00
ELN Respiratory gaseous exchange,blood circulation NM 000501 4.75
EGF Angiogenesis, positive regulationof cell proliferation NM 001963 4.30
IL18 Angiogenesis, response tohypoxia NM 001562 3.85
VEGFA Angiogenesis, ovarian follicledevelopment NM 001025366 3.16
Signal transduction
and regulation
PRLR Cell surface receptor linkedsignaling pathway NM 000949 90.61
RASSF3 Signal transduction NM 178169 12.27
RERG GTPase mediated signaltransduction NM 032918 11.98
STC2 Cell surface receptor linkedsignaling pathway NM 003714 11.37
CD244 Signal transduction NM 016382 8.83
ASPN
Negative regulation of
transforming growth factor beta
receptor signaling pathway
NM 017680 8.20
LPHN3 G-protein coupled receptorprotein signaling pathway NM 015236 7.72
SPSB1 Intracellular signaling pathway NM 025106 6.87
ALCAM Signal transduction, motor axonguidance NM 001627 3.96
Cell regulation and
proliferation
UPK1B Epithelial cell differentiation NM 006952 45.66
MYOCD Cardiac cell differentiation NM 001146312 40.32
EGFL6 Cell differentiation NM 015507 11.94
PODN Negative regulation of cellproliferation NM 153703 9.96
FAS Positive regulation of necroticcell death NM 000043 9.34
KRT4
Epithelial cell differentiation,
negative regulation of epithelial
cell proliferation
NM 002272 6.52
IGFBP7 Regulation of cell growth NM 001553 6.01
HEMGN Cell differentiation, regulation ofosteoblast differentiation NM 018437 5.70
CDH1 Trophectodermal celldifferentiation NM 004360 5.44
DPT Cell adhesion, negativeregulation of cell proliferation NM 001937 5.13
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Table 2: Continued.
Functional category Genesymbol Biological process Accession number
Absolute fold
change
Cytokine, chemokine,
and immune response
IL1RL1 Immune response NM 016232 36.22
S100A8 Chemotaxis, inflammatoryresponse NM 002964 26.48
DPP4 Regulation of T cell mediatedimmunity NM 001935 18.16
ITGB6 Inflammatory response NM 000888 15.01
IGF2BP1 Regulation of cytokinebiosynthetic process NM 006546 9.59
LY96 Inflammatory response, cellulardefense response NM 015364 8.40
CCRL1 Chemotaxis, immune response NM 178445 7.81
ANLN Cytokinesis NM 018685 7.60
CMKLR1 Chemotaxis, immune response NM 001142343 7.41
CD97 Inflammatory response, immuneresponse NM 078481 6.96
CXCL1 Chemotaxis, inflammatoryresponse, immune response NM 001511 5.54
IL33 Positive regulation ofmacrophage activation NM 033439 5.29
CXCR1 Chemotaxis, inflammatoryresponse NM 000634 3.48
CXCL6 Chemotaxis, inflammatoryresponse NM 002993 3.07
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Figure 2: Relative gene expression of mesenchymal stem cell and induced pluripotent stem cell markers using cDNA microarray (a). The
relative differences in the expression of stem cell markers between umbilical cord and dental pulp were analyzed using qRT-PCR (b). Data
are presented as means ± standard deviation and expressed as the relative change by applying the equation 2−ΔCt, where ΔCt = Ct of the gene
minus Ct of the 18S rRNA.
MSCs derived from the UC would be more committed to
angiogenesis. In DP tissue, microarray results indicated that
certain genes (DMP1, AMBN, DSPP, DLX1, RUNX2, LEF1,
PAX9, and MSX1) related to odontogenesis and biomineral
tissue development were upregulated, which was in agree-
ment with the expected results for this biological process.
In addition, genes that might be related to bone and dentin
mineralization, including PHEX, CALB1, MMP20, ALPL,
LHX8, and WNT10A, were upregulated. Microarray data
showed that the expression of DMP1, DSPP, and CALB that
play important roles in the development of pulp tissue was
99.2, 98.1, and 41.3 times higher, respectively, in DP than in
UC. qRT-PCR results indicated that the fold differences in the
expression of DMP1, CALB1, and AMBN were not observed
in the UC. Similarly, IHC staining results showed thatDMP1,
CALB1, andDSPPwere not stained in theUCbutwere stained
around the outer area of DP. The genetic pattern analysis of
permanent pulp indicated that CALB1, a representative gene
in DP, is necessary for enamel mineralization in transition-
and maturation-stage ameloblasts [17].
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Table 3: Representative differentially expressed genes with higher expression levels in dental pulp tissue than in umbilical cord.
Functional category Genesymbol Biological process
Accession
number
Absolute fold
change
Biomineral tissue
development
PHEX Bone and dentin mineralization NM 000444 160.01
DMP1 Bone and dentin mineralization NM 004407 99.20
CALB1 Hydroxyapatite formation NM 004929 98.07
MMP20 Regulation of enamel mineralization,proteolysis NM 004771 85.26
AMBN Bone mineralization, odontogenesis ofdentine-containing tooth NM 016519 65.69
DSPP Odontogenesis of dentine-containing tooth NM 014208 41.26
ALPL Biomineral tissue development NM 000478 14.83
DLX1 Odontogenesis of dentine-containing tooth NM 178120 9.55
LHX8 Odontogenesis of dentine-containing tooth NM 001001933 7.56
CA2 Odontogenesis of dentine-containing tooth NM 000067 7.07
RUNX2 Ossification, osteoblast differentiation NM 001024630 6.53
LEF1 Odontogenesis of dentine-containing tooth NM 016269 6.24
PAX9 Tooth development NM 006194 5.79
MSX1 Odontogenesis, craniofacial development NM 002448 4.04
WNT10A Regulation of odontogenesis ofdentine-containing tooth NM 025216 3.87
Developmental
process
DLX5 Osteoblast differentiation NM 005221 30.01
DLX3 Multicellular organismal development NM 005220 26.13
ADAM22 Proteolysis, central nervous systemdevelopment NM 021723 25.00
NES Central nervous system development NM 006617 15.67
BMP7 Ossification, organ morphogenesis NM 001719 15.60
BMPR1B Skeletal system development, cartilagecondensation NM 001203 13.53
MSX2 Skeletal system development, osteoblastdifferentiation NM 002449 9.32
COL11A2 Skeletal system morphogenesis, cartilagedevelopment, palate development NM 001163771 8.55
BMP5 Skeletal system development, ossification NM 021073 6.08
TBX3 Blood vessel development, in uteroembryonic development NM 016569 5.93
MBP Central nervous system development,myelination NM 001025101 4.95
DLX6 Multicellular organismal development,nervous system development NM 005222 4.12
NRCAM Axonogenesis, central nervous systemdevelopment NM 001193582 4.09
SNAI1 Osteoblast differentiation, mesodermformation NM 005985 3.78
HLF Multicellular organismal development,rhythmic process NM 002126 3.23
BMP2 Development of bone and cartilage NM 001200 2.11
Physiological process
TF Controlling iron concentrations,erythropoiesis NM 001063 153.98
SCN7A Sodium ion transport, muscle contraction NM 002976 82.36
APOD Lipid metabolic process NM 001647 41.22
PLAT Response to hypoxia, blood coagulation NM 000930 10.20
CD52 Elevation of cytosolic calcium ionconcentration NM 001803 4.29
CYGB Response to oxidative stress, oxygentransport NM 134268 3.98
MYOT Muscle contraction NM 006790 3.26
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Table 3: Continued.
Functional category Genesymbol Biological process
Accession
number
Absolute fold
change
Signal transduction
and regulation
WIF1 Wnt receptor signaling pathway NM 007191 70.19
PTN Transmembrane receptor protein signalingpathway NM 002825 38.17
WNT5A Oncogenesis, embryogenesis NM 003392 13.68
NCAM1 Neurite outgrowth, synaptic plasticity NM 181351 7.87
NCAM2 Neurite outgrowth, synaptic plasticity NM 004540 7.38
RASGRF2 Induction of apoptosis by extracellularsignals NM 006909 6.88
CHN1 Signal transduction NM 001822 6.56
MET Cell surface receptor linked signalingpathway NM 001127500 3.01
Cell regulation and
proliferation
SCIN Negative regulation of cell proliferation NM 001112706 58.65
RELN Cell morphogenesis involved indifferentiation NM 005045 49.12
NES Structural organization of the cell NM 006617 15.67
MEGF10 Phagocytosis NM 032446 9.89
EPCAM Positive regulation of cell proliferation NM 002354 8.79
PDGFD Positive regulation of cell division NM 025208 5.43
CLU Cell death, positive regulation of cellproliferation NM 001831 5.19
VEGFC Angiogenesis, positive regulation ofneuroblast proliferation NM 005429 3.74
MSI2 Stem cell development NM 138962 3.55
DBC1 Cell cycle arrest, cell death NM 014618 3.32
TGFB1 Cell growth, cell proliferation, celldifferentiation and apoptosis NM 000660 3.14
IGFBP6 Regulation of cell growth NM 002178 3.07
Cytokine, chemokine,
and immune response
IGJ Immune response NM 144646 22.65
IGHD Immune response BC021276 11.30
CXCL14 Chemotaxis, immune response, inhibitingangiogenesis NM 004887 8.74
SELE Leukocyte migration involved ininflammatory response NM 000450 5.82
MX1 Induction of apoptosis, defense response,response to virus NM 002462 5.24
IFI44 Response to virus NM 006417 5.05
CX3CL1 Chemotaxis, defense response, immuneresponse NM 002996 3.60
CFI Innate immune response NM 000204 3.17
MSCs possess multilineage differentiation potential with
a variety of chemokines, cytokines, and growth factors
involved in the regeneration of damaged tissue. They are
capable of modifying their molecular activities and functions
in response to the environment. The exclusive expression of
the chemokines CXCL1 and CXCL6 in the UC may increase
propagation of hematopoietic precursors in coculture set-
tings. Other genes expressed at higher levels in the UC
include those encoding IL-6, IL-18, FGF9, FGF10, PDGFA,
EGF, and VEGFA, which are part of interconnected pathways
related to angiogenesis. Jin et al. reported that MSCs derived
from bone marrow, adipose tissue, and the UC have signifi-
cantly different anti-inflammatory capacities and confirmed
that UC-MSCs exhibit the greatest anti-inflammatory effects
[20].These findings suggest that UC-MSCs are more efficient
for clinical applications involving revascularization.
In this study, the comparison of stemness of UC and
DP tissues revealed no significant fold difference in the
expression of several surface markers (CD29, CD34, CD44,
CD73, CD105, and CD106) typical for MSCs. Nevertheless,
some differences were observed in the expression level of
CD146 (MCAM) and CD166 (ALCAM), which connect the
control of cell growth with cell migration. These findings are
representative of the developmental process. The qRT-PCR
results showed that the expression levels of CD146 andCD166
were higher in UC than in DP (18.3-fold and 8.24-fold, resp.).
These molecular differences in tissue-specific MSC gene
expression may reflect their functional activities in distinct
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Figure 3: Immunohistochemical (IHC) staining of umbilical cord tissues. IHC staining for DSPP (a, e), DMP1 (b, f), CALB1 (c, g), and CD146
(d, h). CD146 is expressed on arteries of the umbilical cord, suggesting that the majority of stem cells arise from the microvasculature. (scale
bars: (a)–(d) 4mm, (e)–(h) 200𝜇m).
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Figure 4: Immunohistochemical (IHC) staining of dental pulp tissue. IHC staining for DSPP (a, e). DSPP was noted in pulpal tissue, the
odontoblast layer, and primary and secondary dentin. IHC staining for DMP1 (b, f) and CALB1 (c, g). CALB1 was especially expressed in
pulpal tissue and the odontoblast layer. IHC staining for CD146 (d, h) (scale bars: (a)–(d) 4mm, (e)–(h) 200𝜇m).
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niches. A study utilizing flow cytometry reported higher
expression of CD146, amarker expressed on both BMSCs and
DP-MSCs [21]. IHC data confirmed that CD146 is a marker
of vascular endothelial cells expressed on arteries of the UC
and the outer walls of blood vessels in DP, suggesting that
the majority of stem cells arise from the microvasculature.
Accumulating evidence suggests that the expression ofCD166
reflects the onset of a cellular program involving neural
development, branching organ development, hematopoiesis,
the immune response, and tumor progression [22]. Struys
et al. reported that cultured DPSCs and UC-MSCs showed
a similar expression pattern of antigens characteristic of
MSCs such as CD105, CD29, CD44, CD146, and STRO-1
[23]. DPSCs are also identified by their positive expression
of CD29, CD44, CD73, CD90, CD105, and STRO-1 [19].
CD34 protein is a specific antigen in hematopoietic cells,
indicating that a greater number of immature hematopoietic
cells are present in both UC and DP [24]. CD34 is present
on the outer cell walls of DP and in the connective tissue of
the UC, in agreement with previous studies reporting that
CD34 localizes on large blood vessels, but not capillaries
[25].
The expression of pluripotent stem cell genes in the
UC and DP might reflect their embryonic origin. iPSCs are
the most promising cell source for cell-based therapy in
regenerative medicine, as they give rise to development by
introducing 4 factors: MYC, KLF4, OCT4, and SOX2 [7]. No
significant differences were found between the expressions
of these factors in the two tissue types; MYC, KLF4, OCT4,
and SOX2 were expressed 1.57, 1.03, 1.20, and 1.20 times more
highly, respectively, in UC than in DP tissue. Previously,
DPSCs were characterized by the low levels of expression of
undifferentiated cell-associated genes, such as OCT4, MYC,
andNanog,which are considered to facilitate reprogramming
[26]. Recent studies utilizing the UC to derive iPSCs are
expected to contribute to the further expansion of its pluripo-
tency for therapeutic purposes, including drug discovery [27,
28].
TheUC expresses specific embryonic cell markers such as
DLK1, DKK1, TBX18, WNT4, and TGFB3. Previous studies
describing the expression of embryonic cell markers in the
UChave shown that fetal perivascular cells express Runx1 and
OCT-4 at different levels, which characterizes the undifferen-
tiated stem cell state [29]. Interestingly, UC-MSCs exhibited
higher levels of expression of genes related to cell proliferation
than DPSCs, whereas DPSCs exhibited a higher proliferation
rate compared with BMSCs in vitro [11]. Previous study
revealed similar result of this research that UC-MSCs seemed
to have higher cell proliferation ability, while DP-MSCs
may have significant differences for lower cell apoptosis,
osteogenic differentiation, and senescence [30]. This may
be attributed to the developmental state of tissues, as UC
samples are at an earlier stage of development compared
with DP from fully developed and erupted permanent teeth.
Commonly expressed genes in DP include those coding for
various growth factors (BMP-2, BMP-5, BMP-7,MMP20, and
TGF-𝛽1) implicated as strong promoters of the formation
of mineralized bone matrix and tooth morphogenesis [31].
Coexpression of genes with known functions, and unknown
or novel genes, may provide a simple means to obtain data
about genes for which little information is available.
Although the results of this study are still limited and
require further investigation using additional methods, the
similarity between MSCs derived from the UC and DP
at the transcription level definitively places both tissues as
potentially more accessible sources of MSCs. Furthermore,
the present gene expression analysis confirms similarities
between MSCs derived from the UC and DP and provides
molecular and biological insights into the developmental
mechanisms involved in angiogenic and odontogenic pro-
cesses.
5. Conclusions
Here, we presented comparative gene expression data for
human UC and DP tissue. Although UC tissue showed
similar but slightly higher expression patterns, with the usual
MSC markers, both tissues clearly diverged in their differen-
tiation capacity. Further research is necessary to understand
and describe the significance of these findings for clinical
applications.
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